Soligenix (SNGX) Revenue & Revenue Breakdown
Soligenix Revenue Highlights
Latest Revenue (Y)
$839.36K
Latest Revenue (Q)
$2.34K
Main Segment (Y)
CiVax
Soligenix Revenue by Period
Soligenix Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $839.36K | -11.55% |
| 2022-12-31 | $948.91K | 15.12% |
| 2021-12-31 | $824.27K | -65.07% |
| 2020-12-31 | $2.36M | -49.04% |
| 2019-12-31 | $4.63M | -11.67% |
| 2018-12-31 | $5.24M | -3.52% |
| 2017-12-31 | $5.43M | -48.01% |
| 2016-12-31 | $10.45M | 19.16% |
| 2015-12-31 | $8.77M | 24.50% |
| 2014-12-31 | $7.04M | 118.45% |
| 2013-12-31 | $3.22M | 2.53% |
| 2012-12-31 | $3.14M | -58.96% |
| 2011-12-31 | $7.66M | 293.44% |
| 2010-12-31 | $1.95M | -30.84% |
| 2009-12-31 | $2.82M | 21.89% |
| 2008-12-31 | $2.31M | 83.64% |
| 2007-12-31 | $1.26M | -45.61% |
| 2006-12-31 | $2.31M | -24.80% |
| 2005-12-31 | $3.08M | 208.35% |
| 2004-12-31 | $997.48K | 1090.07% |
| 2003-12-31 | $83.82K | 100.00% |
| 2002-12-31 | - | 100.00% |
| 2001-12-31 | - | 100.00% |
| 2000-12-31 | - | -100.00% |
| 1999-12-31 | $1.00 | -100.00% |
| 1998-12-31 | $200.00K | 100.00% |
| 1997-12-31 | $100.00K | 100.00% |
| 1996-01-31 | - | - |
Soligenix generated $839.36K in revenue during NA 2023, up -11.55% compared to the previous quarter, and up 16.01% compared to the same period a year ago.
Soligenix Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $2.34K | -98.00% |
| 2024-03-31 | $117.03K | -52.20% |
| 2023-12-31 | $244.81K | 87.68% |
| 2023-09-30 | $130.44K | -36.96% |
| 2023-06-30 | $206.93K | -19.54% |
| 2023-03-31 | $257.18K | -29.75% |
| 2022-12-31 | $366.07K | 120.34% |
| 2022-09-30 | $166.14K | -27.34% |
| 2022-06-30 | $228.64K | 21.58% |
| 2022-03-31 | $188.06K | -31.78% |
| 2021-12-31 | $275.65K | 48.04% |
| 2021-09-30 | $186.20K | -13.33% |
| 2021-06-30 | $214.82K | 45.55% |
| 2021-03-31 | $147.59K | -53.99% |
| 2020-12-31 | $320.79K | -47.31% |
| 2020-09-30 | $608.81K | 20.49% |
| 2020-06-30 | $505.29K | -45.35% |
| 2020-03-31 | $924.55K | 34.92% |
| 2019-12-31 | $685.26K | -45.39% |
| 2019-09-30 | $1.25M | -18.77% |
| 2019-06-30 | $1.54M | 34.96% |
| 2019-03-31 | $1.14M | 12.81% |
| 2018-12-31 | $1.01M | -26.54% |
| 2018-09-30 | $1.38M | -19.95% |
| 2018-06-30 | $1.73M | 54.10% |
| 2018-03-31 | $1.12M | -13.10% |
| 2017-12-31 | $1.29M | -29.28% |
| 2017-09-30 | $1.82M | 83.87% |
| 2017-06-30 | $990.97K | -25.54% |
| 2017-03-31 | $1.33M | -21.64% |
| 2016-12-31 | $1.70M | -42.60% |
| 2016-09-30 | $2.96M | -6.35% |
| 2016-06-30 | $3.16M | 20.11% |
| 2016-03-31 | $2.63M | -11.49% |
| 2015-12-31 | $2.97M | -23.38% |
| 2015-09-30 | $3.88M | 252.75% |
| 2015-06-30 | $1.10M | 34.74% |
| 2015-03-31 | $816.29K | -57.63% |
| 2014-12-31 | $1.93M | -30.89% |
| 2014-09-30 | $2.79M | 96.56% |
| 2014-06-30 | $1.42M | 55.75% |
| 2014-03-31 | $910.60K | -33.97% |
| 2013-12-31 | $1.38M | 341.30% |
| 2013-09-30 | $312.49K | -50.58% |
| 2013-06-30 | $632.28K | -29.77% |
| 2013-03-31 | $900.35K | 12.16% |
| 2012-12-31 | $802.72K | -13.84% |
| 2012-09-30 | $931.63K | 22.12% |
| 2012-06-30 | $762.85K | 17.83% |
| 2012-03-31 | $647.42K | -0.88% |
| 2011-12-31 | $653.13K | -88.73% |
| 2011-09-30 | $5.80M | 1328.19% |
| 2011-06-30 | $405.82K | -49.78% |
| 2011-03-31 | $808.00K | 163.47% |
| 2010-12-31 | $306.67K | -64.36% |
| 2010-09-30 | $860.52K | 93.53% |
| 2010-06-30 | $444.64K | 32.41% |
| 2010-03-31 | $335.80K | -71.70% |
| 2009-12-31 | $1.19M | 54.80% |
| 2009-09-30 | $766.64K | 130.70% |
| 2009-06-30 | $332.31K | -37.34% |
| 2009-03-31 | $530.32K | -1.55% |
| 2008-12-31 | $538.64K | -11.08% |
| 2008-09-30 | $605.74K | 24.06% |
| 2008-06-30 | $488.24K | -27.95% |
| 2008-03-31 | $677.64K | 115.62% |
| 2007-12-31 | $314.28K | - |
Soligenix generated $2.34K in revenue during Q2 2024, up -98.00% compared to the previous quarter, and up 0.91% compared to the same period a year ago.
Soligenix Revenue Breakdown
Soligenix Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| CiVax | $1.50M | $1.50M | - | - | - |
| Contract revenue | - | $600.00K | $33.35K | - | - |
| Grant revenue | - | - | $790.92K | - | - |
| VaccinesBioDefenseMember | - | - | - | $2.24M | - |
| BioTherapeuticsMember | - | - | - | $117.37K | - |
| Bio Therapeutics | - | - | - | - | $1.23M |
| Vaccines Bio Defense | - | - | - | - | $3.40M |
Soligenix's latest annual revenue breakdown by segment (product or service), as of Dec 23: CiVax (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grant revenue | $117.03K | $166.14K | $228.64K | $138.06K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| CiVax | - | - | $1.50M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Public Health Solutions | - | - | - | $334.14K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| License | - | - | - | - | - | $50.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Contract revenue | - | - | - | - | - | - | $50.00K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Government Contract | - | - | - | - | - | - | - | $700.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Civax | - | - | - | - | - | - | - | $1.50M | - | - | - | - | - | - | - | - | - | - | - | - |
| Grant | - | - | - | - | - | - | - | - | $214.82K | - | - | - | - | - | - | - | - | - | - | - |
| PublicHealthSolutionsMember | - | - | - | - | - | - | - | - | - | $147.59K | - | - | - | - | - | - | - | - | - | - |
| BioTherapeuticsMember | - | - | - | - | - | - | - | - | - | - | - | $64.34K | $37.28K | - | - | - | - | - | - | - |
| VaccinesBioDefenseMember | - | - | - | - | - | - | - | - | - | - | $320.79K | $544.47K | $468.01K | - | - | - | - | - | - | - |
| Bio Therapeutics | - | - | - | - | - | - | - | - | - | - | - | - | - | $15.74K | $50.55K | $263.82K | $449.10K | $464.44K | $217.66K | $280.13K |
| Vaccines Bio Defense | - | - | - | - | - | - | - | - | - | - | - | - | - | $908.81K | $634.71K | $991.09K | $1.10M | $680.35K | $797.12K | $1.10M |
Soligenix's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Grant revenue (100.00%).
Soligenix Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CiVax | $1.50M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Public Health Solutions | - | $334.14K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Grant revenue | - | - | $166.14K | $228.64K | $138.06K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| License | - | - | - | $50.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Contract revenue | - | - | - | - | $50.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Government Contract | - | - | - | - | - | $700.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Civax | - | - | - | - | - | $1.50M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Grant | - | - | - | - | - | - | $214.82K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| PublicHealthSolutionsMember | - | - | - | - | - | - | - | $147.59K | - | - | - | - | - | - | - | - | - | - | - | - |
| BioTherapeuticsMember | - | - | - | - | - | - | - | - | - | $64.34K | $37.28K | - | - | - | - | - | - | - | - | - |
| VaccinesBioDefenseMember | - | - | - | - | - | - | - | - | $320.79K | $544.47K | $468.01K | - | - | - | - | - | - | - | - | - |
| Bio Therapeutics | - | - | - | - | - | - | - | - | - | - | - | $15.74K | $50.55K | $263.82K | $449.10K | $464.44K | $217.66K | $280.13K | $276.50K | $310.52K |
| Vaccines Bio Defense | - | - | - | - | - | - | - | - | - | - | - | $908.81K | $634.71K | $991.09K | $1.10M | $680.35K | $797.12K | $1.10M | $1.45M | $809.26K |
Soligenix's latest quarterly revenue breakdown by geography, as of Mar 23: CiVax (100.00%).
Soligenix Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ENSC | Ensysce Biosciences | $2.23M | - |
| ADXN | Addex Therapeutics | $1.61M | $235.00K |
| BXRX | Baudax Bio | $1.27M | - |
| SNGX | Soligenix | $839.36K | $2.34K |
| PALI | Palisade Bio | $250.00K | - |
| CNSP | CNS Pharmaceuticals | - | - |
| ZURA | Zura Bio | - | - |
| DRMA | Dermata Therapeutics | - | - |
| ERYP | PHAXIAM Therapeutics | - | - |
| ATXI | Avenue Therapeutics | - | - |
| CFRX | ContraFect | - | - |
| PHIO | Phio Pharmaceuticals | - | - |
| IMMX | Immix Biopharma | - | - |
| ALLR | Allarity Therapeutics | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |
| WINT | Windtree Therapeutics | - | - |
SNGX Revenue FAQ
What is Soligenix’s yearly revenue?
Soligenix's yearly revenue for 2023 was $839.36K, representing a decrease of -11.55% compared to 2022. The company's yearly revenue for 2022 was $948.91K, representing an increase of 15.12% compared to 2021. SNGX's yearly revenue for 2021 was $824.27K, representing a decrease of -65.07% compared to 2020.
What is Soligenix’s quarterly revenue?
Soligenix's quarterly revenue for Q2 2024 was $2.34K, a -98.00% decrease from the previous quarter (Q1 2024), and a -98.87% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $117.03K, a -52.20% decrease from the previous quarter (Q4 2023), and a -54.49% decrease year-over-year (Q1 2023). SNGX's quarterly revenue for Q4 2023 was $244.81K, a 87.68% increase from the previous quarter (Q3 2023), and a -33.12% decrease year-over-year (Q4 2022).
What is Soligenix’s revenue growth rate?
Soligenix's revenue growth rate for the last 3 years (2021-2023) was 1.83%, and for the last 5 years (2019-2023) was -81.87%.
What are Soligenix’s revenue streams?
Soligenix's revenue streams in c 23 are CiVax
What is Soligenix’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Soligenix was CiVax. This segment made a revenue of $1.5M, representing 100.00% of the company's total revenue.